Molecular cancer diagnostics revenues are likely to grow faster than 20% per year, from ~$5 billion today to more than $24 billion in 2030.
Source
Verdict
Not graded yet.
All captured fields
- idea
- Molecular Cancer Diagnostics
- target year
- 2030
- metric
- molecular cancer diagnostics revenue (US)
- value
- 24
- unit
- USD billion (lower bound)
- subject
- Molecular cancer diagnostics
- page
- 95
- confidence
- high
- note
- Same slide: enterprise value of molecular cancer testing companies from about USD 30 billion (2022) to USD 145 billion (2030).